Search results
Results From The WOW.Com Content Network
Remifentanil, marketed under the brand name Ultiva is a potent, short-acting synthetic opioid analgesic drug. It is given to patients during surgery to relieve pain and as an adjunct to an anaesthetic. Remifentanil is used for sedation as well as combined with other medications for use in general anesthesia.
For pain relief after surgery, use can decrease the amount of inhalational anesthetic needed for emergence from anesthesia. [32] Balancing this medication and titrating the drug based on expected stimuli and the person's responses can result in stable blood pressure and heart rate throughout a procedure and a faster emergence from anesthesia ...
As opposed to chronic pain, which can last well after an injury or illness has been treated, acute pain is more sudden – often caused by surgery or injury – and is easier to treat in the short ...
Opioid-related deaths in Ontario had increased by 242% from 1969 to 2014. [135] By 2009 in Ontario there were more deaths from oxycodone overdoses than from cocaine overdoses. [136] Deaths from opioid pain relievers had increased from 13.7 deaths per million residents in 1991 to 27.2 deaths per million residents in 2004. [137]
Sufentanil offers properties of sedation and can be used as analgesic component of anesthetic regimen during an operation. [9]Because of its extremely high potency, it is often used in surgery and post-operative pain management for patients that are heavily opioid dependent/opioid tolerant because of long term opiate use for chronic pain or illicit opiate use.
Zohydro was approved for treating chronic pain, but the coalition is concerned about the drug's potency and abuse potential,' WWLP reports. A petition on Change.org calls Zohydro "the next OxyContin."
The heroin and opioid abuse epidemic is hitting America hard with heroin use more than doubling in the past decade among young adults, according to the CDC. While the dire statistics tell the ...
Oxymorphone (sold under the brand names Numorphan and Opana among others) is a highly potent opioid analgesic indicated for treatment of severe pain. Pain relief after injection begins after about 5–10 minutes, after oral administration it begins after about 30 minutes, and lasts about 3–4 hours for immediate-release tablets and 12 hours for extended-release tablets. [6]